Clinical Trial Update: Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer [Phase 2]

View source ↗

Summary

This Phase II trial evaluated preoperative therapy with gefitinib in combination with chemotherapy for estrogen receptor-negative breast cancer and has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED